These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19687248)

  • 1. Susceptibility of urinary tract bacteria to fosfomycin.
    Maraki S; Samonis G; Rafailidis PI; Vouloumanou EK; Mavromanolakis E; Falagas ME
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4508-10. PubMed ID: 19687248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial susceptibility of Gram-negative nonurinary bacteria to fosfomycin and other antimicrobials.
    Samonis G; Maraki S; Rafailidis PI; Kapaskelis A; Kastoris AC; Falagas ME
    Future Microbiol; 2010 Jun; 5(6):961-70. PubMed ID: 20521939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial susceptibility of Gram-positive non-urinary isolates to fosfomycin.
    Falagas ME; Maraki S; Karageorgopoulos DE; Kastoris AC; Kapaskelis A; Samonis G
    Int J Antimicrob Agents; 2010 May; 35(5):497-9. PubMed ID: 20226634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin.
    Falagas ME; Maraki S; Karageorgopoulos DE; Kastoris AC; Mavromanolakis E; Samonis G
    Int J Antimicrob Agents; 2010 Mar; 35(3):240-3. PubMed ID: 20034765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of fosfomycin tromethamine against extended spectrum beta-lactamase producing urinary tract bacteria.
    Khan IU; Mirza IA; Ikram A; Ali S; Hussain A; Ghafoor T
    J Coll Physicians Surg Pak; 2014 Dec; 24(12):914-7. PubMed ID: 25523727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The susceptibility to fosfomycin of Gram-negative bacteria isolates from urinary tract infection in the Czech Republic: data from a unicentric study.
    Fajfr M; Louda M; Paterová P; Ryšková L; Pacovský J; Košina J; Žemličková H; Broďák M
    BMC Urol; 2017 Apr; 17(1):33. PubMed ID: 28446177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the in vitro activity of fosfomycin tromethamine against Gram-negative bacterial strains recovered from community- and hospital-acquired urinary tract infections in Turkey.
    Demir T; Buyukguclu T
    Int J Infect Dis; 2013 Nov; 17(11):e966-70. PubMed ID: 23742831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Short communication: comparison of susceptibilities of Escherichia coli urinary tract isolates against fosfomycin tromethamine and different antibiotics].
    Aykut Arca E; Karabiber N
    Mikrobiyol Bul; 2007 Jan; 41(1):115-9. PubMed ID: 17427560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
    Cho YH; Jung SI; Chung HS; Yu HS; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K
    Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fosfomycin for the treatment of drug-resistant urinary tract infections: potential of an old drug not explored fully.
    Patwardhan V; Singh S
    Int Urol Nephrol; 2017 Sep; 49(9):1637-1643. PubMed ID: 28616818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of fosfomycin when tested against US contemporary bacterial isolates.
    Flamm RK; Rhomberg PR; Watters AA; Sweeney K; Ellis-Grosse EJ; Shortridge D
    Diagn Microbiol Infect Dis; 2019 Feb; 93(2):143-146. PubMed ID: 30236530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility of vancomycin-resistant enterococci (VRE) to fosfomycin.
    Perri MB; Hershberger E; Ionescu M; Lauter C; Zervos MJ
    Diagn Microbiol Infect Dis; 2002 Apr; 42(4):269-71. PubMed ID: 12007445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.
    Liu HY; Lin HC; Lin YC; Yu SH; Wu WH; Lee YJ
    J Microbiol Immunol Infect; 2011 Oct; 44(5):364-8. PubMed ID: 21524974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of disk susceptibility testing of fosfomycin tromethamine.
    Pfaller MA; Barry AL; Fuchs PC
    Diagn Microbiol Infect Dis; 1993 Jul; 17(1):67-70. PubMed ID: 8359009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of frequent urinary pathogens to fosfomycin trometamol and eight other antibiotics: results of an Italian multicenter survey.
    Schito GC; Chezzi C; Nicoletti G; Moreddu M; Arcangeletti MC; Stefani S; Albini E; Del Bono GP
    Infection; 1992; 20 Suppl 4():S291-5. PubMed ID: 1294520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fosfomycin: In vitro efficacy against multidrug-resistant isolates beyond urinary isolates.
    Demir T; Buyukguclu T
    J Glob Antimicrob Resist; 2017 Mar; 8():164-168. PubMed ID: 28167307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fosfomycin susceptibility of urinary Escherichia coli isolates producing extended-spectrum beta-lactamase according to CLSI and EUCAST recommendations].
    Cağan Aktaş S; Gençer S; Batırel A; Hacıseyitoğlu D; Ozer S
    Mikrobiyol Bul; 2014 Oct; 48(4):545-55. PubMed ID: 25492650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of fosfomycin trometamol against pathogens from urinary tract infections: a Spanish multicenter study.
    García-Rodríguez JA; Trujillano Martín I; Baquero F; Cisterna R; Gobernado M; Liñares F; Martín-Luengo F; Piédrola G
    J Chemother; 1997 Dec; 9(6):394-402. PubMed ID: 9491838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Synergic action of the combination of fosfomycin and kanendomycin against gram-positive and gram-negative bacteria].
    Russo G; Toscano MA; Gismondo MR; Nicolosi V; Garaci E
    Ann Sclavo; 1980; 22(1):77-82. PubMed ID: 7247487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies.
    Falagas ME; Kastoris AC; Karageorgopoulos DE; Rafailidis PI
    Int J Antimicrob Agents; 2009 Aug; 34(2):111-20. PubMed ID: 19403273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.